Core Points - The article outlines the working rules of the Strategic Committee of Wuxi Xiangsheng Medical Technology Co., Ltd, emphasizing its role in the company's long-term strategic planning and major investment feasibility studies [1][2][3] Group 1: General Provisions - The Strategic Committee is established to ensure the scientific nature of the company's development planning and strategic decision-making, enhancing sustainable development capabilities [1] - The committee consists of three directors, including at least one independent director, with the company chairman serving as the committee's head [1][2] Group 2: Responsibilities and Authority - The committee is responsible for researching and proposing suggestions on the company's medium and long-term development plans, operational goals, and strategic investments [1][12] - It has the authority to review and analyze the execution of the previous year's strategic plans and suggest adjustments based on the company's actual situation [1][12] Group 3: Meeting Procedures - The committee can convene meetings as needed, with notifications sent at least three days in advance [3][6] - A quorum of two-thirds of the committee members is required for meetings to be held, and decisions are made based on majority votes [6][29] Group 4: Decision-Making and Record-Keeping - Decisions made by the committee must be documented and reported to the board of directors, with records maintained for at least ten years [39][11] - The committee's resolutions are effective upon signing by attending members, and any violations of legal or regulatory requirements may result in joint liability for participating members [41][11]

无锡祥生医疗科技股份有限公司 董事会提名委员会工作细则 第一章 总则 第二章 人员组成 第四章 会议的召开与通知 第十六条 提名委员会可根据需要召开会议。 提名委员会主任或二名以上委员联名可要求召开提名委员会会议。 第十七条 提名委员会会议主要对公司董事、总经理及其他高级管理人员上一年 度的工作表现及是否存在需要更换董事、总经理及其他高级管理人员 的情形进行讨论和审议。 第一条 为完善无锡祥生医疗科技股份有限公司(以下简称"公司")法人治理 结构, 增强董事会选举程序的科学性、民主性, 优化董事会的组成人 员结构, 公司特设立董事会提名委员会(以下简称"提名委员会")。 第二条 为使提名委员会规范、高效地开展工作, 公司董事会根据《中华人民 共和国公司法》(以下简称"《公司法》") 、《上市公司独立董事管 理办法》等有关法律、法规和规范性文件及《无锡祥生医疗科技股份 有限公司章程》(以下简称"《公司章程》")的有关规定, 制定本工作 细则。 第三条 提名委员会是董事会按照股东会决议设立的专门工作机构, 主要负责 向公司董事会提出更换、推荐新任董事候选人及高级管理人员候选人 的意见或建议, 对董事会负责。 第四 ...

Group 1 - The company has established an Audit Committee under the Board of Directors to enhance decision-making and ensure effective supervision of the management team [1][4] - The Audit Committee consists of three directors, with at least two being independent directors, and is chaired by an independent director with accounting expertise [2][5] - The Audit Committee is responsible for reviewing financial information, supervising internal and external audits, and ensuring the establishment of effective internal controls [4][6] Group 2 - The Audit Committee must have a majority of its members present to exercise its powers, and it is required to hold at least one meeting each quarter [11][23] - The committee is tasked with evaluating the company's internal control systems and must report on its findings alongside the annual financial report [7][9] - The Audit Committee is also responsible for hiring and supervising external auditors, ensuring their independence and adherence to professional standards [10][13] Group 3 - The committee must disclose its annual performance and activities on the Shanghai Stock Exchange website alongside the company's annual report [4][6] - In case of any irregularities, the Audit Committee is obligated to prompt the Board to take necessary actions and disclose relevant information [7][10] - The committee's decisions require a majority vote from all members, and any conflicts of interest must be disclosed and managed appropriately [42][49]

Core Points - The document outlines the implementation details for the online voting system for the shareholders' meeting of Wuxi Xiangsheng Medical Technology Co., Ltd, aiming to standardize the voting process and protect investors' rights [1][2][3] Group 1: General Provisions - The rules are established in accordance with relevant laws and regulations, including the Company Law of the People's Republic of China and the Shanghai Stock Exchange listing rules [2][3] - The online voting system is defined as a technology platform that allows shareholders to exercise their voting rights remotely [2][3] Group 2: Notification and Preparation for Online Voting - The company must notify shareholders who are registered by the equity registration date about the online voting options and prepare accordingly [3][4] - The company can sign a service agreement with a designated information company to provide online voting services [4][5] Group 3: Methods and Procedures for Online Voting - Shareholders can vote through the trading system or the internet voting platform, with specific time frames for each [6][7] - Multiple accounts held by a shareholder can be used to participate in online voting, with the total voting rights calculated based on all accounts [8][9] Group 4: Statistics and Inquiry of Voting Results - The company must ensure accurate and complete voting data is sent to the information company for statistical purposes [9][10] - After the voting concludes, shareholders can check their voting results through the information company's website [10][11] Group 5: Supplementary Provisions - The rules will take effect upon approval by the shareholders' meeting and will be interpreted by the company's board of directors [11]

无锡祥生医疗科技股份有限公司 内部审计制度 第一章 总则 第二章 内审部的设立 第三章 内部审计职责 第一条 为加强无锡祥生医疗科技股份有限公司(以下简称"公司"或"本公司") 内部审计工作, 提高内部审计工作质量, 维护公司和投资者的合法权益, 依据《中华人民共和国审计法》《审计署关于内部审计工作的规定》《上 海证券交易所科创板股票上市规则》等有关法律、法规、规范性文件和《无 锡祥生医疗科技股份有限公司章程》(以下简称"公司章程")的规定, 结合 公司实际情况, 制定本制度。 第二条 本制度适用于公司及下属子公司的内部审计管理。 第三条 本制度所称内部审计, 是指由公司内部审计机构或人员, 对本公司及下属 公司财政财务收支、经济活动、内部控制、风险管理实施独立、客观的监 督、评价和建议, 以促进单位完善治理、实现目标的活动。 第四条 本制度所称内部控制, 是指公司董事会、高级管理人员及其他有关人员为 实现下列目标而提供合理保证的过程: (一) 遵守国家法律、法规、规章及其他相关规定; (二) 提高公司经营的效率和效果; (三) 保障公司资产的安全; (四) 确保公司信息披露的真实、准确、完整和公平。 第五条 ...

General Provisions - The company establishes an information disclosure management system to regulate its information disclosure practices, ensuring compliance with relevant laws and regulations, and protecting the rights of investors [1][2] - Information disclosure refers to the timely and fair release of significant information that may impact the trading price of the company's stock or investment decisions, through designated media and in accordance with regulatory requirements [4][5] Information Disclosure Obligations - The company and relevant parties must disclose information that is true, accurate, and complete, without any false records or misleading statements [3][6] - The company must disclose significant events that may affect stock trading prices or investment decisions, even if they do not meet specific disclosure standards [6][7] Disclosure Content and Format - The company is required to disclose periodic reports, including quarterly, semi-annual, and annual reports, as well as temporary reports for significant events [13][16] - The company must ensure that disclosed information is clear, concise, and free from excessive jargon, and that any discrepancies between different language versions are resolved in favor of the Chinese text [11][12] Major Events and Transactions - The company must disclose major events that could significantly impact its stock price, including changes in business strategy, major investments, and significant losses [26][27] - Transactions that exceed certain thresholds, such as 10% of total assets or market value, must be disclosed promptly [31][32] Industry Information Disclosure - The company should proactively disclose industry information that may significantly affect stock trading prices or investor decisions, including industry characteristics and competitive advantages [41][42] - Any significant changes in industry conditions or the company's business operations must be disclosed in a timely manner [43][44]

Core Viewpoint - The document outlines the investor relations management system of Wuxi Xiangsheng Medical Technology Co., Ltd, emphasizing the importance of effective communication between the company and its investors to enhance corporate governance and protect investor rights [2][8]. Group 1: Objectives of Investor Relations Management - The primary goals include fostering a positive relationship with investors, establishing a stable investor base, promoting a culture of respect for investors, maximizing overall company benefits, and increasing transparency in information disclosure [2][3]. Group 2: Principles of Investor Relations Management - The management of investor relations should adhere to compliance, equality, proactivity, and integrity principles, ensuring that all investors, especially minority shareholders, are treated fairly and that their concerns are addressed promptly [2][3][8]. Group 3: Content and Methods of Communication - Key communication topics include the company's development strategy, legal disclosures, operational management information, environmental, social, and governance (ESG) information, and shareholder rights [5][6]. - Various channels and methods for communication are to be utilized, including the company website, new media platforms, and direct interactions such as meetings and presentations [5][6][7]. Group 4: Responsibilities and Organization - The board secretary is responsible for coordinating investor relations activities, while the securities affairs department handles specific tasks related to investor communication and feedback [8][8]. - The company must ensure that all communications are accurate, transparent, and compliant with legal standards, avoiding any misleading or selective disclosures [8][8]. Group 5: Handling Investor Requests and Disputes - The company is obligated to respond to investor requests and manage disputes effectively, ensuring timely communication and resolution of issues raised by investors [6][7].

在委员人数达到规定人数三人以前, 薪酬与考核委员会暂停行使本 工作细则规定的职权。 第十条 《公司法》《公司章程》关于董事义务的规定适用于薪酬与考核委 员会委员。 第三章 职责权限 董事会对薪酬与考核委员会的建议未采纳或者未完全采纳的, 应当 在董事会决议中记载薪酬与考核委员会的意见及未采纳的具体理由, 并进行披露。 第一条 为建立健全无锡祥生医疗科技股份有限公司(以下简称"公司")董事 (非独立董事)及高级管理人员的考核和薪酬管理制度, 完善公司治 理结构, 公司特设立董事会薪酬与考核委员会(以下简称"薪酬与考 核委员会")。 第二条 为使薪酬与考核委员会规范、高效地开展工作, 公司董事会根据《中 华人民共和国公司法》(以下简称"《公司法》") 、《上市公司独 立董事管理办法》等有关法律、法规和规范性文件以及《无锡祥生 医疗科技股份有限公司章程》(以下简称"《公司章程》")的有关规 定, 制定本工作细则。 第三条 薪酬与考核委员会是董事会按照股东会决议设立的专门工作机构, 主要负责制定公司董事及高级管理人员的考核标准并进行考核; 负 责制定、审查公司董事及高级管理人员的薪酬政策与方案, 对董事会 负责。 第 ...

《无锡祥生医疗科技股份有限公 司章程》(以下简称"《公司章程》")以及其他相关规定, 制定本制度。 无锡祥生医疗科技股份有限公司 关联交易决策制度 第一章 总则 公司拟发生前款第(一)项所述之关联交易的, 还应当提供具有执行证券、 期货相关业务资格的证券服务机构对交易标的出具的审计或者评估报 告。与日常经营相关的关联交易可免于审计或者评估。 公司为关联人提供担保的, 应当具备合理的商业逻辑, 在董事会审议通 过后及时披露, 并提交股东会审议。公司为控股股东、实际控制人及其 关联方提供担保的, 控股股东、实际控制人及其关联方应当提供反担保。 应当披露的关联交易, 应当经公司全体独立董事过半数同意后, 提交董 事会审议并及时披露。 上述同一关联人, 包括与该关联人受同一主体控制, 或者相互存在股权 控制关系的其他关联人。已经按照本制度规定履行相关义务的, 不再纳 入累计计算范围。 (二) 公司应采取有效措施防止关联人通过关联交易垄断公司的采购和 销售业务渠道、干预公司的经营、损害公司利益; (三) 关联交易应当具有商业实质, 价格应当公允,原则上应不偏离市场 独立第三方的价格或收费等交易条件; (四) 关联人如享 ...

无锡祥生医疗科技股份有限公司 募集资金管理办法 第一章 总则 第一条 为加强、规范无锡祥生医疗科技股份有限公司(以下简称"公司")募集 资金的管理, 提高募集资金使用效率和效益, 根据《中华人民共和国公 司法》《中华人民共和国证券法》《上市公司证券发行注册管理办法》 《上市公司募集资金监管规则》 《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》《上海证券交易所科创板股票上市规 则》(以下简称"《上市规则》")等法律法规和规范性文件以及《无锡 祥生医疗科技股份有限公司章程》(以下简称"《公司章程》")的规定, 结合公司实际情况, 特制定本办法。 公司的董事、高级管理人员应当勤勉尽责, 确保公司募集资金安全, 不 得操控公司擅自或变相改变募集资金用途。 第五条 公司的控股股东、实际控制人及其他关联人不得占用公司募集资金, 不得利用公司募集资金投资项目(以下简称"募投项目")获取不正当利 益。 公司发现控股股东、实际控制人及其他关联人占用募集资金的, 应当 及时要求归还, 并披露占用发生的原因、对公司的影响、清偿整改方案 及整改进展情况。 第二章 募集资金存储 第七条 公司应当在募集资金到账后一 ...